Nfocus CE marks brain aneurysm treatment
This article was originally published in Clinica
Executive Summary
Nfocus Neuromedical has CE marked its flagship product, the Luna aneurysm embolisation system, for sale in Europe. It is designed to treat brain aneurysms both before and after rupture, which can lead to stroke, brain damage and death. Luna blocks blood flow to the aneurysm while providing a scaffold that encourages tissue growth across its opening, creating a plug. It is a self-expandable Nitinol implant that can be delivered via a conventional catheter and opened up to its full size once deployed within the aneurysm. Alternatives include surgery, which is "traumatic and expensive", and coils, which may fail to fully treat the aneurysm, according to Nfocus. The Palo Alto, California firm estimates that up to one in 15 people will develop a brain aneurysm in their lifetime.